Skip to content
Search

Latest Stories

PAGB CEO Michelle Riddalls calls receiving OBE 'a major positive reinforcer'

Michelle Riddalls, CEO of PAGB awarded an OBE for her exceptional work in advocating for the over-the-counter (OTC) medicines sector.

She played a vital role during Brexit negotiations, ensuring continued access to OTC medicines in Northern Ireland

Michelle Riddalls, chief executive officer of PAGB—the Consumer Healthcare Association—has been honoured with an Officer of the Order of the British Empire (OBE) in the King's New Year Honours List 2025.

This recognition celebrates her outstanding contributions to advocating for the over-the-counter (OTC) medicines sector.


Speaking to Pharmacy Business, Riddalls expressed her excitement, saying, “It’s such a big positive reinforcer.”

“Making a difference and making things happen has always been a big driver. Since taking on this role at PAGB, I’ve been able to do that more, particularly around Brexit and medicines regulation.

“Receiving this award makes you realize the positive impact you’ve had and understand that it’s appreciated."

Riddalls played a vital role during Brexit negotiations, ensuring continued access to OTC medicines in Northern Ireland and supporting self-care initiatives across the UK.

She has provided oral evidence numerous times to the House of Lords Select Committee on the NI Protocol Bill and actively engaged with the Medicines and Healthcare products Regulatory Agency (MHRA) during the rollout of the Windsor Framework.

Her leadership contributed to the publication of a national self-care policy in 2023 and the re-establishment of the Reclassification Alliance, which aims to improve patient access to self-treatable products and reduce NHS prescribing costs.

Riddalls added: “This recognition is beyond anything I could have imagined receiving for doing a job that I am so passionate about, and I feel deeply honoured.

“Contributing to the self-care agenda and the role played by increased availability of OTC medicines in self-care gives me a personal sense of satisfaction and benefits consumers, GP practices and community pharmacy as well as the OTC medicines industry.”

Riddalls, who began her career in the OTC industry in 2001 in the regulatory field, shared that what she has always enjoyed about the sector is the immediate impact of her work in enhancing access to medicines and enabling people to self care.

One of her significant achievements was facilitating the reclassification of Viagra from a prescription-only medicine (POM) to a pharmacy (P) medicine, enabling men to access the medication directly from pharmacies.

Bas Vorsteveld, president of PAGB, praised Michelle’s courage and dedication, stating: “Since Michelle became chief executive in 2020, she has consistently gone above and beyond, contributing her own time disproportionately to supporting the UK government during Brexit as well as championing self-care. We thank her for courage, tenacity and tireless dedication.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less